Tradeline, Inc. filters and categorizes new-construction and industry news from regional and professional journals across the country. Here you will find new projects, products, and regulatory updates.
Industry News
University of Nevada, Las Vegas Breaks Ground on Advanced Engineering Building
The University of Nevada, Las Vegas broke ground on the $75 million Advanced Engineering Building in February of 2022. Located on the Maryland campus, the three-story, 52,000-sf facility will enable the Howard R. Hughes College of Engineering to increase total enrollment from 3,000 to 5,000 students. The ground floor will provide undergraduates with numerous opportunities for experiential learning with a maker space, interactive classrooms, and a flexible auditorium and event venue.
Bristol Myers Squibb Plans Biopharmaceutical R&D Center
Bristol Myers Squibb is partnering with Alexandria Real Estate Equities to create a 427,000-rsf R&D center in San Diego. Located in the Alexandria Point development, the leased facility will provide core labs for the creation of advanced biopharmaceutical therapies. Housing nearly 600 researchers and staff members, the collaborative building will consolidate employees from several regional campuses into a flexible working ecosystem for discovery and innovation.
Arizona State University Completes Construction on Walton Center for Planetary Health
Arizona State University completed construction in early 2022 on the $192 million Rob and Melani Walton Center for Planetary Health in Tempe. Designed by Architekton and Grimshaw, the 281,000-gsf facility provides leading-edge research labs for biological and life sciences, engineering, and sustainability, as well as offering dry labs for programs in computing, cybersecurity, and robotics.
Vermeulens Releases Q4-2021 Market Outlook
Vermeulens has released its market outlook report for the fourth quarter of 2021. Key points include:
Eli Lilly Partners with Alexandria Real Estate Equities on Institute for Genetic Medicine
Eli Lilly & Company is investing approximately $700 million to create the Institute for Genetic Medicine in Boston. Located in the Seaport district, the leased facility will provide 334,000 rsf of leading-edge research space for the discovery of innovative RNA and DNA-based therapies. The project will also include a shared R&D center with dedicated and configurable lab environments to enable biotech start-ups to collaborate with Lilly scientists.